1. Home
  2. AMRX vs BUR Comparison

AMRX vs BUR Comparison

Compare AMRX & BUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMRX
  • BUR
  • Stock Information
  • Founded
  • AMRX 2002
  • BUR 2009
  • Country
  • AMRX United States
  • BUR Guernsey
  • Employees
  • AMRX N/A
  • BUR N/A
  • Industry
  • AMRX Biotechnology: Pharmaceutical Preparations
  • BUR Finance: Consumer Services
  • Sector
  • AMRX Health Care
  • BUR Finance
  • Exchange
  • AMRX Nasdaq
  • BUR Nasdaq
  • Market Cap
  • AMRX 2.7B
  • BUR 3.0B
  • IPO Year
  • AMRX N/A
  • BUR 2010
  • Fundamental
  • Price
  • AMRX $8.47
  • BUR $13.20
  • Analyst Decision
  • AMRX Strong Buy
  • BUR Strong Buy
  • Analyst Count
  • AMRX 5
  • BUR 2
  • Target Price
  • AMRX $10.00
  • BUR $18.00
  • AVG Volume (30 Days)
  • AMRX 1.1M
  • BUR 771.7K
  • Earning Date
  • AMRX 11-08-2024
  • BUR 11-07-2024
  • Dividend Yield
  • AMRX N/A
  • BUR 0.95%
  • EPS Growth
  • AMRX N/A
  • BUR N/A
  • EPS
  • AMRX N/A
  • BUR 1.16
  • Revenue
  • AMRX $2,680,420,000.00
  • BUR $1,284,243,000.00
  • Revenue This Year
  • AMRX $17.56
  • BUR N/A
  • Revenue Next Year
  • AMRX $3.23
  • BUR $30.54
  • P/E Ratio
  • AMRX N/A
  • BUR $11.27
  • Revenue Growth
  • AMRX 12.32
  • BUR 1129.87
  • 52 Week Low
  • AMRX $4.16
  • BUR $12.07
  • 52 Week High
  • AMRX $9.48
  • BUR $16.77
  • Technical
  • Relative Strength Index (RSI)
  • AMRX 45.78
  • BUR 44.00
  • Support Level
  • AMRX $7.52
  • BUR $13.15
  • Resistance Level
  • AMRX $9.48
  • BUR $14.72
  • Average True Range (ATR)
  • AMRX 0.35
  • BUR 0.40
  • MACD
  • AMRX 0.02
  • BUR -0.08
  • Stochastic Oscillator
  • AMRX 48.59
  • BUR 4.40

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

About BUR Burford Capital Limited

Burford Capital Ltd is a finance firm providing litigation finance, insurance, and risk transfer, law firm lending, corporate intelligence and judgment enforcement, and a wide range of investment activities. It operates in two segments: Capital provision, which is the provision of capital to the legal industry or in connection with legal matters, both directly and through investment in the group's managed funds; Asset management and other services, which includes the provision of services to the legal industry, including litigation insurance; and other corporate. The geographical segments include the United States, United Kingdom, Singapore, Hong Kong, China, and, Australia.

Share on Social Networks: